CARA DAVIS: Open Payments
NPI 1952338782 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,010 in 86 payments from 25 companies in 2025. Trend: 2023 $2,234 · 2024 $2,248 · 2025 $2,010
Food & beverage: $2,010
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $371 |
| Novo Nordisk Inc | 15 | $288 |
| Amgen Inc. | 12 | $255 |
| ABBVIE INC. | 9 | $161 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $159 |
| Axsome Therapeutics, Inc. | 6 | $121 |
| PFIZER INC. | 4 | $78 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $70 |
| Bausch Health US, LLC | 4 | $69 |
| Lilly USA, LLC | 3 | $58 |
Products named: AIRSUPRA, Kerendia, REPATHA, Ozempic, BREZTRI, XIFAXAN, APLENZIN, Sunosi.
Industry payments across NC — which companies pay providers there.
